| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.0009 | 1 |